Riskpilot← Back to searchSign inGet full accessGrindeks Kalceks Sverige AB
ABActiveOrg 5594440041Kontinentplan 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20231 employees
Revenue 2024
SEK 4,1M
EBITDA margin
-112.8%
-404% vs 2023
Equity ratio
0.3%
Financial strength
Net profit 2024
SEK -5,9M
-541% vs 2023
| Revenue | SEK 4,1M | — |
| EBITDA | SEK -4,7M | -404% |
| Net profit | SEK -5,9M | -541% |
| Total assets | SEK 9,8M | +2771% |
| Equity | SEK 25K | +0% |
| Employees | 1 | — |
Legal name
Grindeks Kalceks Sverige AB
Org number
5594440041
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 augusti 2023
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva distribution av och partihandel med läkemedel och aktiva läkemedelsingredienser (API), inklusive men inte begränsat till deltagande i offentlig upphandling och försäljning till'sjukhus;'marknadsundersökning; detaljhandel med medicin- tekniska varor på apotek (kemibutiker) och därmed förenlig verksamhet.
Address
Kontinentplan 2
Email
sebastian.larsson@grindeks.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 4 130 |
| Staff expenses | — | — |
| EBITDA | −924 | −4 660 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −924 | −4 660 |
| Net financials | 1 | −1 248 |
| Profit before tax | −922 | −5 909 |
| Tax | −0 | −0 |
| Net profit | −922 | −5 909 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 343 | 9 849 |
| Equity | 25 | 25 |
| Long-term debt | 0 | 0 |
| Short-term debt | 318 | 9 824 |
| Total debt | 318 | 9 824 |
EBITDA margin
-112.8%
This company
15.8%
Market median
-814% vs market
20232024
Equity ratio
0.3%
This company
38.2%
Market median
-99% vs market
20232024
Return on equity
-23636.0%
This company
18.4%
Market median
-128557% vs market
20232024
Net profit margin
-143.1%
This company
8.1%
Market median
-1867% vs market
20232024
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20232024
Debt / equity
392.96×
This company
0.62×
Market median
-63281% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BS Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
JC Authorized Recipient of Service | Authorized Recipient of Service | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2023 – 2025 | |
| Deputy Board Member | 2023 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Grindeks Kalceks Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Sebastian Larsson | Chief Executive Officer | 0 companies |
| Jakob Carl Olsson | Authorized Recipient of Service | 0 companies |
| Juris Hmelnickis | Board of Directors | 0 companies |
| Andrejs Liberts | Deputy Board Member | 0 companies |
| Janis Romanovskis | Board of Directors | 0 companies |